Home/Filings/4/0001144204-14-015167
4//SEC Filing

SKYSTAR BIO-PHARMACEUTICAL CO 4

Accession 0001144204-14-015167

CIK 0001076939operating

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 5:00 PM ET

Size

5.2 KB

Accession

0001144204-14-015167

Insider Transaction Report

Form 4
Period: 2014-03-10
LU WEIBING
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2014-03-10+250,0001,422,459 total
Footnotes (2)
  • [F1]Stock grant pursuant to the Company's 2010 Stock Incentive Plan as approved by the Board of Directors, issuable in four equal quarterly installments, each year for the term of his employment agreement with the Company.
  • [F2]Includes shares of common stock of the Company which are held by Upform Group Limited.

Issuer

SKYSTAR BIO-PHARMACEUTICAL CO

CIK 0001076939

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001076939

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:00 PM ET
Size
5.2 KB